跳至主要内容
临床试验/NCT02484989
NCT02484989已完成不适用

UK Surveillance of Treated Retinopathy of Prematurity

Moorfields Eye Hospital NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 270 人开始时间: 2013年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
270
试验地点
1
主要终点
Incidence of babies requiring treatment for retinopathy of prematurity in the UK

研究概览

简要总结

Currently, there is little recent data on regional variations in treatment methods, neonatal units that provide retinopathy (ROP) treatment, facilities for treatment available at each unit including anaesthetic support for such preterm babies, facilities to transfer babies to units that offer treatment etc. While some parts of the UK have established neonatal networks and agreements among units for ROP treatment, in other parts, such arrangements are illdefined.

The number of babies needing ROP treatment may be higher since the introduction of revised guidelines in 2008 as earlier treatment has been shown to be beneficial. Collecting epidemiological data through the British Ophthalmic Surveillance Unit (BOSU) on the incidence of treatable ROP, the treatment methods used and facilities for treatment will provide the foundation for effective planning of resources and manpower to deal with the additional demand.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
— 至 1 Year(Child)
性别
All
接受健康志愿者

入选标准

  • Any baby with ROP who is treated or referred to another unit for treatment either in the form of laser therapy, cryotherapy, antiVEGF agent or vitrectomy/scleral buckling (or a combination of above treatments)

排除标准

  • None; we will monitor data to exclude duplication of cases which may arise from children being transferred between neonatal units or consultants

结局指标

主要结局

Incidence of babies requiring treatment for retinopathy of prematurity in the UK

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验